KBC Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
KBC Group's NEO Position: Q2 2026 in Review
KBC Group held its NeoGenomics (NEO) position steady in Q2 2026 at 6,557 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.
KBC Group first reported a position in NEO in Q1 2019 and has held it in 23 quarters since. The position peaked at $638K in Q2 2019. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- KBC Group held 6,557 shares of NeoGenomics worth $96K as of Q2 2026.
- KBC Group left its NeoGenomics share count unchanged in Q2 2026.
- NeoGenomics made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1446 holding.
- KBC Group first reported a position in NeoGenomics in Q1 2019 and has held it in 23 quarters since.
- KBC Group's NeoGenomics position peaked at $638K in Q2 2019.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.